This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (37)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Ophthalmology  • Diabetic Retinopathy  • Macular Disorders  • Ophthalmological Procedures, Other  • Drug Therapy, Other  • Endocrine Diseases  • Diabetes Mellitus  • Alert me on articles by topic  Social Bookmarking   What's this?

A Systematic Review

Quresh Mohamed, MD; Mark C. Gillies, MD, PhD; Tien Y. Wong, MD, PhD

JAMA. 2007;298(8):902-916.

Context  Diabetic retinopathy (DR) is the leading cause of blindness in the working-aged population in the United States. There are many new interventions for DR, but evidence to support their use is uncertain.

Objective  To review the best evidence for primary and secondary intervention in the management of DR, including diabetic macular edema.

Evidence Acquisition  Systematic review of all English-language articles, retrieved using a keyword search of MEDLINE (1966 through May 2007), EMBASE, Cochrane Collaboration, the Association for Research in Vision and Ophthalmology database, and the National Institutes of Health Clinical Trials Database, and followed by manual searches of reference lists of selected major review articles. All English-language randomized controlled trials (RCTs) with more than 12 months of follow-up and meta-analyses were included. Delphi consensus criteria were used to identify well-conducted studies.

Evidence Synthesis  Forty-four studies (including 3 meta-analyses) met the inclusion criteria. Tight glycemic and blood pressure control reduces the incidence and progression of DR. Pan-retinal laser photocoagulation reduces the risk of moderate and severe visual loss by 50% in patients with severe nonproliferative and proliferative retinopathy. Focal laser photocoagulation reduces the risk of moderate visual loss by 50% to 70% in eyes with macular edema. Early vitrectomy improves visual recovery in patients with proliferative retinopathy and severe vitreous hemorrhage. Intravitreal injections of steroids may be considered in eyes with persistent loss of vision when conventional treatment has failed. There is insufficient evidence for the efficacy or safety of lipid-lowering therapy, medical interventions, or antivascular endothelial growth factors on the incidence or progression of DR.

Conclusions  Tight glycemic and blood pressure control remains the cornerstone in the primary prevention of DR. Pan-retinal and focal retinal laser photocoagulation reduces the risk of visual loss in patients with severe DR and macular edema, respectively. There is currently insufficient evidence to recommend routine use of other treatments.

Author Affiliations: Centre for Eye Research Australia, University of Melbourne and Royal Victorian Eye and Ear Hospital, Melbourne, Australia (Drs Mohamed and Wong); Cheltenham General Hospital, Cheltenham, England (Dr Mohamed); Save Sight Institute, University of Sydney, Australia (Dr Gillies); Singapore Eye Research Institute, Yong Loo Lin School of Medicine, National University of Singapore (Dr Wong).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Retinopathy
Janet M. Torpy, Tiffany J. Glass, and Richard M. Glass
JAMA. 2007;298(8):944.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Rates of Progression in Diabetic Retinopathy During Different Time Periods: A systematic review and meta-analysis
Wong et al.
Diabetes Care 2009;32:2307-2313.
ABSTRACT | FULL TEXT  

Strain-Dependent Increases in Retinal Inflammatory Proteins and Photoreceptor FGF-2 Expression in Streptozotocin-Induced Diabetic Rats
Kirwin et al.
IOVS 2009;50:5396-5404.
ABSTRACT | FULL TEXT  

Flicker Light-Induced Retinal Vasodilation in Diabetes and Diabetic Retinopathy
Nguyen et al.
Diabetes Care 2009;32:2075-2080.
ABSTRACT | FULL TEXT  

Is Routine Pupil Dilation Safe among Asian Patients with Diabetes?
Tan et al.
IOVS 2009;50:4110-4113.
ABSTRACT | FULL TEXT  

Inflammatory, Hemostatic, and Other Novel Biomarkers for Diabetic Retinopathy: The Multi-Ethnic Study of Atherosclerosis
Nguyen et al.
Diabetes Care 2009;32:1704-1709.
ABSTRACT | FULL TEXT  

Advances in the Medical Treatment of Diabetic Retinopathy
Simo and Hernandez
Diabetes Care 2009;32:1556-1562.
FULL TEXT  

Abnormal Angiogenesis in Diabetic Nephropathy
Nakagawa et al.
Diabetes 2009;58:1471-1478.
FULL TEXT  

Tyrosine Phosphorylation of Vitreous Inflammatory and Angiogenic Peptides and Proteins in Diabetic Retinopathy
Reverter et al.
IOVS 2009;50:1378-1382.
ABSTRACT | FULL TEXT  

Diabetes and Obesity: A Challenge for Every Ophthalmologist
Gardner and Gabbay
Arch Ophthalmol 2009;127:328-329.
FULL TEXT  

Systemic management of diabetic retinopathy
Liew et al.
BMJ 2009;338:b441-b441.
FULL TEXT  

Resource Use and Costs Associated With Diabetic Macular Edema in Elderly Persons
Shea et al.
Arch Ophthalmol 2008;126:1748-1754.
ABSTRACT | FULL TEXT  

Screening Uptake in a Well-Established Diabetic Retinopathy Screening Program: The role of geographical access and deprivation
Leese et al.
Diabetes Care 2008;31:2131-2135.
ABSTRACT | FULL TEXT  

Ocular Associations of Diabetes Other Than Diabetic Retinopathy
Jeganathan et al.
Diabetes Care 2008;31:1905-1912.
FULL TEXT  

Precision and Reliability of Retinal Thickness Measurements in Foveal and Extrafoveal Areas of Healthy and Diabetic Eyes
Tangelder et al.
IOVS 2008;49:2627-2634.
ABSTRACT | FULL TEXT  

Targets of Tyrosine Nitration in Diabetic Rat Retina
Zhan et al.
Mol. Cell. Proteomics 2008;7:864-874.
ABSTRACT | FULL TEXT  

Preventing and managing diabetic complications in elderly patients
HORNICK and ARON
Cleveland Clinic Journal of Medicine 2008;75:153-158.
ABSTRACT | FULL TEXT